Stockreport

Celldex Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF US$2.92 loss per share (further deteriorated from US$2.40 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period Celldex [Read more]